期刊文献+

超剂量拉莫三嗪与丙戊酸钠联用致全身皮疹 被引量:2

Generalized skin eruptions related to overdose of lamotrigine combined with valproate sodium
原文传递
导出
摘要 1例41岁男性患者胶质母细胞瘤切除术后出现癫痫,给予奥卡西平(初始剂量为0.3g,2次/d,后加至0.6g,2次/d)和丙戊酸钠(500mg、1次/d)口服,因癫痫控制不佳加用拉莫三嗪(25mg鼻饲、2次/d)。加用拉莫三嗪第17天因出现肺感染给予头孢曲松(2g静脉滴注、1次/d)。加用拉莫三嗪第19天,患者面颈部、胸背部、双上肢、腹部、双下肢依次出现鲜红色斑丘疹,部分融合成片,诊断为药疹。停用拉莫三嗪和头孢曲松,奥卡西平和丙戊酸钠继续应用,并给予地塞米松,葡萄糖酸钙、维生素c等治疗。5d后患者皮损好转,9d后皮疹消退。 A 41-year-old man with epilepsy after glioblastoma resection received oral oxcarbazepine (an initial dose of 0.3 g twice daily, which was increased to 0.6 g twice daily) and valproate sodium (500 mg, once daily). Nasal feeding lamotrigine 25 mg twice daily was added to her regimen due to poor control of epileptic condition. On day 17 of lamotrigine therapy, an IV infusion of ceftriaxone 2 g once daily was given for pulmonary infection. On day 19 of lamotrigine therapy, the patient developed red maculopapular eruptions successively on the face, neck, chest, back, arms, abdomen and legs, some rashes fused into [amella. He was diagnosed drug eruptions. Lamotrigine and ceftriaxone were discontinued immediately. Oxearbazepine and valproate sodium were continued. He was given dexamethasone, calcium glueonate and vitamin C. Five days later, his skin lesions were improved. Nine days after lamotrigine withdrawal, the skin eruptions subsided.
出处 《药物不良反应杂志》 CSCD 2015年第6期471-472,共2页 Adverse Drug Reactions Journal
关键词 拉莫三嗪 丙戊酸 药疹 Lamotrigine Valproic acid Drug eruptions
  • 相关文献

参考文献8

二级参考文献52

  • 1吴洁.丙戊酸钠缓释片致重症多形红斑[J].药物不良反应杂志,2006,8(2):144-144. 被引量:1
  • 2FLESCH G.Overview of the clinical pharmacokinetics of oxcarbazepine[J].Clin Drug Investig,2004,24(4):185-203.
  • 3VAISLEIB I I,NEFT R A.Overnight transition from carbamazepine to oxcarbazepine in children and adolescents[J].Pharmacotherapy,2008,28(10):1211-1214.
  • 4ALVESTAD S,LYDERSEN S,BRODTKORB E.Cross-reactivity pattern of rash from current aromatic antiepileptic drugs[J].Epilepsy Res,2008,80(2-3):194-200.
  • 5陈新谦 金有豫 汤光.新编药物学[M]15版[M].北京:人民卫生出版社,2003.583.
  • 6李端.药理学[M].5版.北京:人民卫生出版社,2003:345.
  • 7国家药典委员会.中华人民共和国药典临床用药须知:化学药和生物制品卷[M].北京:人民卫生出版社,2005:856-940.
  • 8Perucca E. An introduction to antiepileptic drugs [J]. Epilepsia, 2005, 46(suppl 4): 31-37.
  • 9Klitgaard H, Verdru P. Levetiracetam: the first SV2A ligand for the treatment of epilepsy [J]. Expert Opin Drug Discov, 2007, 2(11): 1537-1545.
  • 10Jevtovic-Todorovic V, Todorovic SM. The role of peripheral T-type calcium channels in pain transmission [J]. Cell Calcium, 2006, 40(2): 197-203.

共引文献133

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部